A previous study suggested that high levels of B-type natriuretic peptide (BNP), a marker of heart failure, were significantly higher in the eosinopenia group, which is consistent with previous reports suggesting its importance in treatment decision-making for COVID-19 patients (22). The gene discussed is NPPB; the disease is COVID-19.